logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
01/09/2025
The 20-year Japanese government bond yield rose by 2 basis points to 2.620%.
Latest
2 m ago
Nobel laureate warns: Lack of regulation of stablecoins could lead to governments being forced to provide assistance.
2 m ago
Financial report outlook | Salesforce (CRM.US) Q2 revenue forecast exceeds $10.1 billion, AI business ARR breaks billion and becomes a new growth engine?
5 m ago
On September 1st, Sihuan Pharmaceutical announced on the Hong Kong Stock Exchange that in order to promote the deep application and industrialization of artificial intelligence technology (AI) in the research and development of medical aesthetics products, the Group has signed a framework agreement with Shenyuan Zhiyao Biological Technology (Beijing) Co., Ltd. (referred to as "Shenyuan Zhiyao"). The two parties will jointly establish an AI research and development company led by the Group to explore the development of new medical aesthetic products driven by AI. This move marks the Group's strategic layout in the "AI + medical aesthetics" innovation track entering a substantive stage.
5 m ago
The Fourth Ring Pharmaceutical and Shenyuan Natural Medicine jointly established an AI research and development company to explore the development of new medical and cosmetic products driven by AI.
6 m ago
Huaxin Cement successfully acquired a well-known listed company in Nigeria.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.